Related Experiment Video
Updated: Jun 25, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
Feasibility of remimazolam rescue sedation for neonatal MRI: a case report
Di Wu1, Lin Chen1, Jing Cheng1
1Department of Anesthesiology, Maternal and Child Health Hospital of Hubei Province, Wuhan, China.
Background:
High-quality neonatal imaging often necessitates sedation or anesthesia to minimize motion artifacts. However, procedural sedation for non-painful pediatric examinations outside the operating room presents unique challenges due to their distinct cardiopulmonary physiology and drug metabolism. Although remimazolam is associated with minimal hemodynamic and respiratory effects in adults, evidence supporting its use in neonatal MRI remains limited.
Case Description:
We report the first successful application of remimazolam for MRI sedation in an early-term neonate (37 ⁴⁄₇ weeks' gestational age, 2.9 kg). After unsuccessful non-pharmacologic measures and intranasal dexmedetomidine, intravenous remimazolam (0.1 mg/kg) produced adequate sedation within 1 min, allowing completion of a 17-minute MRI examination while preserving hemodynamic and respiratory stability.
Conclusions:
This case highlights potential utility of remimazolam s a rescue sedative for neonatal MRI sedation. Comprehensive multicenter studies are warranted to evaluate its safety, efficacy, and role in clinical practice.
Insights
Remimazolam, a sedative, was successfully used for neonatal MRI sedation in a single case. This offers a potential rescue option for challenging neonatal imaging procedures requiring sedation.
Area of Science:
- Neonatal imaging
- Pediatric anesthesiology
- Pharmacology
Background:
- Neonatal imaging requires sedation to reduce motion artifacts.
- Sedation in neonates presents unique challenges due to physiological differences.
- Limited evidence exists for remimazolam's use in neonatal MRI.
Purpose of the Study:
- To report the first use of remimazolam for neonatal MRI sedation.
- To assess the efficacy and safety of remimazolam in a neonatal case.
Main Methods:
- Case report of an early-term neonate (37 ⁴⁄₇ weeks GA, 2.9 kg).
- Intravenous remimazolam (0.1 mg/kg) administered after other methods failed.
- Monitoring of hemodynamic and respiratory stability during MRI.
Main Results:
- Successful sedation achieved within 1 minute of remimazolam administration.
- 17-minute MRI completed with preserved cardiorespiratory function.
- Remimazolam demonstrated rapid onset and stability.
Conclusions:
- Remimazolam shows potential as a rescue sedative for neonatal MRI.
- Further multicenter studies are needed to confirm safety and efficacy.
- Investigating remimazolam's role in clinical practice is warranted.
Related Concept Videos
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Parenteral Anesthetics: Overview